Table 4 Factors associated with the acceptance of regular vaccines (if available in the future) (n = 322)
Factor | Crude OR | 95%CI | Adjusted OR | 95%CI | p-value |
|---|---|---|---|---|---|
Gender | |||||
Female | 1.00 (reference) | 1.00 (reference) | |||
Male | 1.30 | 0.71–2.37 | 1.53 | 0.71–3.03 | 0.22 |
Education level | |||||
Undergraduate (Bachelor) | 1.00 (reference) | 1.00 (reference) | |||
Graduate (Master or PhD) | 1.24 | 0.64–2.40 | 1.56 | 0.75–3.27 | 0.24 |
Study background | |||||
Health sciences | 1.00 (reference) | 1.00 (reference) | |||
Non-health sciences | 1.11 | 0.58–2.13 | 1.24 | 0.63–2.46 | 0.52 |
School or job mandate | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 1.20 | 0.57–2.52 | 1.16 | 0.51–2.66 | 0.73 |
Vaccine accessibility | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 2.34 | 1.13–4.84 | 1.96 | 0.80–4.79 | 0.14 |
Side effects | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 2.38 | 0.91–6.19 | 1.87 | 0.63–5.17 | 0.28 |
Safety | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 3.09 | 0.68–14.06 | 2.31 | 0.25–15.09 | 0.41 |
Vaccine costs | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 1.46 | 0.79–2.69 | 1.09 | 0.55–2.25 | 0.81 |
COVID-19 infection history or close contact with COVID-19 patients | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 1.25 | 0.62–2.51 | 0.95 | 0.41–2.24 | 0.92 |
Social responsibility | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 1.13 | 0.38–3.41 | 0.35 | 0.08–1.68 | 0.27 |
Scientific evidence | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 3.59 | 1.48–8.72 | 3.44 | 1.21–9.77 | 0.02a |
Efficacy | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 4.65 | 0.84–25.84 | 6.04 | 0.54–67.43 | 0.14 |
Future career requirements | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 0.58 | 0.19–1.81 | 0.20 | 0.04–1.07 | 0.20 |